RAYCARE LIMITED

Company Registration Number:
05312918 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

RAYCARE LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

RAYCARE LIMITED

Balance sheet

As at 31 March 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 4,532,956 4,379,484
Total fixed assets: 4,532,956 4,379,484
Current assets
Debtors:   416,337 238,793
Cash at bank and in hand: 457,767 345,717
Total current assets: 874,104 584,510
Creditors: amounts falling due within one year:   (216,484) (173,311)
Net current assets (liabilities): 657,620 411,199
Total assets less current liabilities: 5,190,576 4,790,683
Creditors: amounts falling due after more than one year:   (2,216,197) (2,363,013)
Total net assets (liabilities): 2,974,379 2,427,670
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 2,974,279 2,427,570
Shareholders funds: 2,974,379 2,427,670

The notes form part of these financial statements

RAYCARE LIMITED

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 01 December 2025
and signed on behalf of the board by:

Name: Mr R Weiniger
Status: Director

The notes form part of these financial statements

RAYCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

RAYCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 96 94

RAYCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Tangible Assets

Total
Cost £
At 01 April 2024 5,486,759
Additions 244,541
At 31 March 2025 5,731,300
Depreciation
At 01 April 2024 1,107,275
Charge for year 91,069
At 31 March 2025 1,198,344
Net book value
At 31 March 2025 4,532,956
At 31 March 2024 4,379,484